4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · IEX Real-Time Price · USD

14.40

-0.74 (-4.89%)

At close: Jul 19, 2024, 4:00 PM

14.55

+0.15 (1.04%)

Pre-market: Jul 22, 2024, 7:29 AM EDT

4D Molecular Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	20.45	20.72	3.13	18.04	13.61	6.99	Upgrade
Revenue Growth (YoY)	826.69%	562.29%	-82.65%	32.52%	94.85%	-50.56%	Upgrade
Gross Profit	20.45	20.72	3.13	18.04	13.61	6.99	Upgrade
Selling, General & Admin	38.8	36.49	32.91	28.01	17.24	13.9	Upgrade
Research & Development	102.55	97.1	80.25	61.36	53.04	38.72	Upgrade
Other Operating Expenses	0	0	0	0	0	5.14	Upgrade
Operating Expenses	141.35	133.59	113.16	89.37	70.28	57.75	Upgrade
Operating Income	-120.9	-112.87	-110.03	-71.33	-56.66	-50.76	Upgrade
Other Expense / Income	-16.34	-12.03	-2.54	-0.02	0.03	-1.46	Upgrade
Pretax Income	-104.56	-100.84	-107.49	-71.32	-56.69	-49.31	Upgrade
Net Income	-104.56	-100.84	-107.49	-71.32	-56.69	-49.31	Upgrade
Shares Outstanding (Basic)	49	39	32	28	6	5	Upgrade
Shares Outstanding (Diluted)	49	39	32	28	6	5	Upgrade
Shares Change	50.57%	20.95%	16.66%	331.23%	25.05%	1.85%	Upgrade
EPS (Basic)	-2.44	-2.58	-3.32	-2.57	-8.82	-9.59	Upgrade
EPS (Diluted)	-2.44	-2.58	-3.32	-2.57	-8.82	-9.59	Upgrade
Free Cash Flow	-79.44	-78.56	-98.22	-78.24	-51.91	-39.91	Upgrade
Free Cash Flow Per Share	-1.61	-2.01	-3.04	-2.82	-8.07	-7.76	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-591.13%	-544.65%	-3516.52%	-395.46%	-416.28%	-726.65%	Upgrade
Profit Margin	-511.23%	-486.59%	-3435.41%	-395.37%	-416.49%	-705.78%	Upgrade
Free Cash Flow Margin	-388.44%	-379.11%	-3139.05%	-433.77%	-381.35%	-571.34%	Upgrade
EBITDA	-98.63	-95.09	-103.61	-68.3	-55.25	-48.3	Upgrade
EBITDA Margin	-482.23%	-458.85%	-3311.41%	-378.63%	-405.89%	-691.41%	Upgrade
Depreciation & Amortization	5.93	5.75	3.88	3.02	1.44	1	Upgrade
EBIT	-104.56	-100.84	-107.49	-71.32	-56.69	-49.31	Upgrade
EBIT Margin	-511.23%	-486.59%	-3435.41%	-395.37%	-416.49%	-705.78%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).